Twentyeight Health, a digital health company offering affordable access and convenience for women’s sexual and reproductive healthcare, today announced that the company has launched in Texas. “Twentyeight Health will be expanding our Medicaid coverage of birth control to Texas residents at a time when access for women on Medicaid has been further limited,” said Amy Fan, co-founder of Twentyeight Health. “As Twentyeight…
UK-based Yoppie, a DTC femtech company focused on subscription-based, organic period care and PMS products has recently announced a £1.2M seed round bringing total funding to £3.4M. The company has now been backed by Vostock New Ventures and Colle Capital. Since its start in 2016 the company has evolved from e-commerce to leveraging tech for logistics, personalization and customer education. The new…
Women First Digital (WFD), a collection of online platforms providing information and counseling services on safe abortion, contraception, and sexual and reproductive health, is launching a new WhatsApp bot extension for Ally, the world’s first ever abortion virtual assistant, in celebration of World Health Day’s 2021 theme: building a fairer, healthier world. WFD is empowering women worldwide to make informed decisions about their…
Rock Health has recently released their Q1 2021 digital health funding report. With $6.7B in US digital health funding Q1 has been the the most-funded quarter to date. Ten years ago, we at Rock Health published our first report on digital health venture investment, highlighting an annual haul of $1.1B from investors into the emerging sector. In each of the last two weeks of…
Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether a wearable device can detect a COVID-19 infection in real-time and alert people to get tested or self-isolate prior to showing symptoms. While other studies to date (including the COVI-GAPP study Ava announced in April 2020) have examined the feasibility of…
Women’s health biotech Celmatix focused uniquely on ovarian biology, today announced that Dr. Adrienne Day has joined the company’s advisory board. Dr. Day joins as the company eyes upcoming nonclinical studies for the lead RSTK agonist program, and continued partnering interest in its category-defining multi-omic ovarian health platform. She will play a key role in supporting the strategic and scientific prioritization of…
Israeli femtech company MobileODT, who are innovating in cervical cancer screening, have announced that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the Dominican Republic. This proof of concept project was initiated as part of the company’s strategic direction in providing cervical cancer screening at scale, utilizing Artificial Intelligence (AI) and Machine Learning (ML) capabilities. The…
Merck and Alydia Health have announced that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will acquire Alydia Health. Alydia Health is a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. PPH is one of the most common complications…
